Je was op zoek naar: cynomolgus (Maltees - Engels)

xadina cynomolgus (macaca fascicularis)
cynomolgus monkey (macaca fascicularis)

omalizumab joħroġ mal- ħalib tax- xadini cynomolgus.
omalizumb is excreted in milk in cynomolgus monkeys.

omalizumab joħroġ mal- ħalib tas- sider tax- xadini cynomolgus.
omalizumb is excreted in breast milk in cynomolgus monkeys.

Ġew imwettqa studji tossikoloġiċi intramuskolari ta’ doża waħda fix-xadini cynomolgus.
single dose intramuscular toxicology studies have been performed in cynomolgus monkeys.

saru studji pivitali mhux kliniċi fuq is-sigurta’ fix-xadina cynomolgus.
the pivotal non-clinical safety studies were conducted in the cynomolgus monkey.

xhur mogħtija lil xadini tar- razza cynomolgus ma kkawżat ebda tossiċità ta ’ importanza.
116 for 3 months caused no remarkable toxicity.

ma kinux osservati effetti avversi f’xadini cynomolgus femminili sesswalment maturi esposti għal pertuzumab.
no adverse effects were observed in sexually mature female cynomolgus monkeys exposed to pertuzumab.

daclizumab jintrema fil-ħalib tax-xadini cynomolgus (ara sezzjoni 5.3).
daclizumab is excreted in cynomolgus monkey milk (see section 5.3).

madankollu, ixekizumab jiġi eliminat f’livelli baxxi fil- ħalib tax-xadini cynomolgus.
however, ixekizumab is excreted at low levels in the milk of cynomolgus monkeys.

minbarra hekk, kien hemm emorraġġija akuta u infjammazzjoni fil- post tal- injezzjoni f’ xadini cynomolgus.
in addition, acute haemorrhage and inflammation were observed at injection sites in cynomolgus monkeys.

minbarra hekk, kien hemm emorraġġija akuta u infjammazzjoni fil- post ta 'l- injezzjoni f’ xadini cynomolgus.
in addition, acute haemorrhage and inflammation were observed at injection sites in cynomolgus monkeys.

11 hemm evidenza ta ’ rispons anafilattiku permezz ta ’ degranulazzjoni ta ’ ċelluli tat- tip mast fix- xadini cynomolgus.
there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.

ma kienx hemm evidenza ta’ rispons anafilattiku permezz ta’ degranulazzjoni ta’ ċelluli tat-tip mast fix-xadini cynomolgus.
there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.

doża ta’ 20 x 106 iu/kg/jum għal 3 xhur mogħtija lil xadini tar-razza cynomolgus ma kkawżat ebda tossiċità ta’ importanza.
daily dosing of cynomolgus monkeys with 20 x 106 iu/kg/day for 3 months caused no remarkable toxicity.

fi studju ta’ sena fuq it-tossiċità fix-xadini tat-tip cynomolgus, abatacept ma ġiex assoċjat ma’ xi tossiċità sinifikanti.
in a one-year toxicity study in cynomolgus monkeys, abatacept was not associated with any significant toxicity.

fi studju tossikoloġiku ta ’ 13- il ġimgħa f’ xadini cynomolgus, feriti fil- ġilda kienu reġistrati b’ dożi ta ’ ≥ 5 mg/ kg/ jum.
12 in a 13-week toxicology study in cynomolgus monkeys, skin lesions have been recorded at doses ≥ 5 mg/kg/day.